Literature DB >> 856375

Sclerosing peritonitis due to practolol: a report on 9 cases and their surgical management.

W K Eltringham, H J Espiner, C W Windsor, D A Griffiths, J D Davies, H Baddeley, A E Read, R J Blunt.   

Abstract

Nine patients with an unusual and serious intraabdominal complication of the beta-adrenergic blocking agent practolol seen since 1973 are reported. The striking and bizarre peritoneal changes induced by the drug have distinctive features that are not shown by other forms of peritoneal disease. The cases presented with small bowel obstruction, usually chronic in type and often associated with profound weight loss and an abdominal mass. Characteristic radiological features were present. The abnormalities at laparotomy were impressive, with a gross proliferation of the visceral peritoneum which formed a dense white cocoon which encased, constricted and markedly shortened the small bowel, usually from the duodenojejunal flexure to the ileocaecal valve. The obstruction was relieved by mobilizing the small bowel from the ensheathing tissue. Restoration of alimentary function after surgery was delayed but the long term result was satisfactory with full relief of symptoms and the absence of recurrent obstruction during the follow-up period. This complication may arise after treatment with the drug has been stopped, and although long term oral therapy has been discontinued, further cases will almost certainly present for some time to come.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 856375     DOI: 10.1002/bjs.1800640402

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  21 in total

1.  Idiopathic sclerosing encapsulating peritonitis (or abdominal cocoon): a report of 5 cases.

Authors:  Ping Xu; Li-Hua Chen; You-Ming Li
Journal:  World J Gastroenterol       Date:  2007-07-14       Impact factor: 5.742

2.  Classification of encapsulating peritoneal sclerosis is important, but must encapsulate the entire spectrum of the disease.

Authors:  Christopher J E Watson; Andrew J Butler; J Andrew Bradley
Journal:  Perit Dial Int       Date:  2013 Sep-Oct       Impact factor: 1.756

3.  Weber-Christian disease producing splenic vein occlusion and bleeding gastric varices: successful treatment with sclerotherapy.

Authors:  D Heseltine; M Bramble; A Cole; D Clarke; W Castle
Journal:  Postgrad Med J       Date:  1990-04       Impact factor: 2.401

4.  Idiopathic sclerosing encapsulating peritonitis presenting as a right iliac fossa mass in a teenaged girl.

Authors:  Hafez Mohammad Ammar Abdullah; Muhammad Asim Shahzad; Sajjad Ullah; Waqas Ullah
Journal:  BMJ Case Rep       Date:  2016-05-09

Review 5.  Encapsulating peritoneal sclerosis.

Authors:  Christopher J Danford; Steven C Lin; Martin P Smith; Jacqueline L Wolf
Journal:  World J Gastroenterol       Date:  2018-07-28       Impact factor: 5.742

6.  Abdominal cocoon.

Authors:  Christian B S Katz; Robert T Diggory; Abdus Samee
Journal:  BMJ Case Rep       Date:  2014-03-28

7.  Abdominal Cocoon.

Authors:  D Chopra; J N Lakhe; S C Sharma; K R Salgotra; Msvk Raju
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 8.  Review of general surgery 1977.

Authors:  H Ellis
Journal:  Postgrad Med J       Date:  1978-06       Impact factor: 2.401

9.  A case of idiopathic encapsulating peritoneal sclerosis with intractable ileus successfully treated by surgery and steroid therapy.

Authors:  Yuuki Ikeda; Yasushi Sato; Yuusuke Kamihara; Masahiro Hirakawa; Hiroyuki Onuma; Kohichi Takada; Tsuyoshi Hayashi; Tsutomu Sato; Koji Miyanishi; Rishu Takimoto; Masayoshi Kohune; Takayuki Nobuoka; Hiroko Noguchi; Motoo Oi; Hisato Honma; Kohichi Hirata; Tadashi Hasegawa; Junji Kato
Journal:  Clin J Gastroenterol       Date:  2013-06-20

10.  Clinical characteristics of dialysis related sclerosing encapsulating peritonitis: multi-center experience in Korea.

Authors:  Beom Seok Kim; Hoon Young Choi; Dong-Ryeol Ryu; Tae Hyun Yoo; Hyeong Cheon Park; Shin Wook Kang; Kyu Hun Choi; Sung Kyu Ha; Dae Suk Han; Ho Yung Lee
Journal:  Yonsei Med J       Date:  2005-02-28       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.